(Q44208377)

30 November 2017

Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer's disease (English)

1 reference

dementia with Lewy bodies

30 November 2017

0 references

1 reference

Kazutomi Kanemaru

1

1 reference

PubMed ID

12420719

30 November 2017

Hiroshi Yamanouchi

series ordinal

2

1 reference

PubMed ID

12420719

30 November 2017

language of work or name

1 reference

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

249

1 reference

30 November 2017

8

1 reference

30 November 2017

1125-1126

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-002-0753-x

30 November 2017

0 references

cites work

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease

1 reference

12 December 2020

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

1 reference

12 December 2020

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies.

1 reference

12 December 2020

18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies

1 reference

12 December 2020

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

1 reference

12 December 2020

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

10.1007/S00415-002-0753-X

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12420719